Stage IVA Cervical Cancer Active Not Recruiting Phase 2 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0028785 (Stage IVA Cervical Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02257528Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical CancerTreatment